Nisa Investment Advisors’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.4K | Buy |
3,604
+1,392
| +63% | +$12.9K | ﹤0.01% | 1720 |
|
|
2025
Q1 | $16.2K | Buy |
2,212
+128
| +6% | +$938 | ﹤0.01% | 1965 |
|
|
2024
Q4 | $17.8K | Buy |
2,084
+137
| +7% | +$1.17K | ﹤0.01% | 1970 |
|
|
2024
Q3 | $16.9K | Sell |
1,947
-406
| -17% | -$3.53K | ﹤0.01% | 1961 |
|
|
2024
Q2 | $16.1K | Buy |
2,353
+30
| +1% | +$205 | ﹤0.01% | 2017 |
|
|
2024
Q1 | $21.1K | Buy |
2,323
+133
| +6% | +$1.21K | ﹤0.01% | 1868 |
|
|
2023
Q4 | $9.77K | Sell |
2,190
-5,882
| -73% | -$26.2K | ﹤0.01% | 2046 |
|
|
2023
Q3 | $25.3K | Hold |
8,072
| – | – | ﹤0.01% | 1938 |
|
|
2023
Q2 | $41.7K | Buy |
8,072
+2,500
| +45% | +$12.9K | ﹤0.01% | 1807 |
|
|
2023
Q1 | $29K | Hold |
5,572
| – | – | ﹤0.01% | 1890 |
|
|
2022
Q4 | $16K | Buy |
5,572
+72
| +1% | +$207 | ﹤0.01% | 2112 |
|
|
2022
Q3 | $20K | Hold |
5,500
| – | – | ﹤0.01% | 2053 |
|
|
2022
Q2 | $22K | Buy |
5,500
+5,000
| +1,000% | +$20K | ﹤0.01% | 2024 |
|
|
2022
Q1 | $2K | Hold |
500
| – | – | ﹤0.01% | 2345 |
|
|
2021
Q4 | $3K | Hold |
500
| – | – | ﹤0.01% | 2117 |
|
|
2021
Q3 | $5 | Hold |
500
| – | – | ﹤0.01% | 2259 |
|
|
2021
Q2 | $7 | Hold |
500
| – | – | ﹤0.01% | 2261 |
|
|
2021
Q1 | $8 | Buy |
+500
| New | +$8 | ﹤0.01% | 2232 |
|